Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000126

Chief Medical Officer sold 2,576 shares at $33.22 ($85,575)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2022-08-19 Sale −2,576 $33.22 $85,575 173,087 I: show line 1 in the form
Open-market sales · 2,576 sh · avg $33.22 · $85,575
Loading xslF345X03/wf-form4_166128752453768.xml…